ProQR Therapeutics N.V.

NASDAQ: PRQR
Share price (3/25/25): $1.61
Market cap (3/25/25): $169 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

ended 12/31/20 FY 2020

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration of securities for employees

Shelf registration

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Van Herk Investments B.V.

Adage Capital Management, L.P.

Van Herk Investments B.V.

Van Herk Investments B.V.

Van Herk Investments B.V.

News Filter

Announces Year End 2024 Operating and Financial Results

Incorporation by Reference

Investor Presentation

Announces $8.1 Million in New Funding From Rett Syndrome Research Trust to Expand RNA Editing Collaboration

Appoints Peter A. Beal, PhD, as Chief ADAR Scientist

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness